Imperial College London

ProfessorElioRiboli

Faculty of MedicineSchool of Public Health

Chair in Cancer Epidemiology and Prevention
 
 
 
//

Contact

 

+44 (0)20 7594 1913e.riboli Website

 
 
//

Assistant

 

Ms Julieta Dourado +44 (0)20 7594 3426

 
//

Location

 

152Medical SchoolSt Mary's Campus

//

Summary

 

Summary

Professor Elio  Riboli is Chair in Cancer Epidemiology and Prevention and was formerly the Director of the School of Public Health at Imperial College London, rated one of the top two epidemiology and public health submissions to the UK’s Research Assessment Exercise (RAE) in 2009. He holds an M.D. degree (1977, State University of Milan), a Master of Public Health (1980, Milan) and a Master of Science in Epidemiology (1982, Harvard University). Professor Riboli is a Registered Physician (General Medical Council, UK, 2005) and an Honorary Fellow of the Royal College of Physicians (2008).

From 1983 to 2005 Professor Riboli was based at Lyon’s the International Agency for Research on Cancer (IARC), where he developed new research projects in the areas of nutrition, nutritional status and cancer. In 1989 he initiated the European Prospective Investigation into Cancer and Nutrition (EPIC), which sampled data from 500,000 subjects across 26 centres in ten countries. He was Head of the Nutrition and Hormones Group of IARC from 2004 to 2005.

Professor Riboli has co-authored over 310 peer-reviewed publications and over 100 book chapters and books and serves on editorial boards of major journals on nutrition, cancer and epidemiology. 

In 2005 he joined Imperial College London as Professor of Cancer Epidemiology; in 2006 he was appointed Divisional Head of Epidemiology, Public Health and Primary Care, which later become the School of Public Health. Professor Riboli stepped down as Head of the School at the end of 2017.


Publications

Journals

Casabonne D, Benavente Y, Seifert J, et al., 2020, Serum levels of hsa-miR-16-5p, hsa-miR-29a-3p, hsa-miR-150-5p, hsa-miR-155-5p and hsa-miR-223-3p and subsequent risk of chronic lymphocytic leukemia in the EPIC study, International Journal of Cancer, Vol:147, ISSN:0020-7136, Pages:1315-1324

Jakszyn P, Cayssials V, Buckland G, et al., 2020, Inflammatory potential of the diet and risk of colorectal cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) study, International Journal of Cancer, Vol:147, ISSN:0020-7136, Pages:1027-1039

Kliemann N, Murphy N, Viallon V, et al., 2020, Predicted Basal metabolic rate and cancer risk in the European Prospective Investigation into Cancer and Nutrition (Epic), International Journal of Cancer, Vol:147, ISSN:0020-7136, Pages:648-661

Tong TYN, Appleby PN, Key TJ, et al., 2020, The associations of major foods and fibre with risks of ischaemic and haemorrhagic stroke: a prospective study of 418 329 participants in the EPIC cohort across nine European countries, European Heart Journal, Vol:41, ISSN:0195-668X, Pages:2632-2640

Sieri S, Agnoli C, Grioni S, et al., 2020, Glycemic index, glycemic load, and risk of coronary heart disease: a pan-European cohort study., Am J Clin Nutr

More Publications